InvestorsHub Logo
Followers 53
Posts 1651
Boards Moderated 0
Alias Born 04/22/2022

Re: dr_lowenstein post# 546812

Friday, 12/09/2022 11:50:21 PM

Friday, December 09, 2022 11:50:21 PM

Post# of 692175
Yes, that is a quote from the article, yet drugs have been approved having only ECAs. In that very same article, they named several of those drugs that I had mentioned. If I recall, the ECA data were deemed supportive, and FDA approval was indeed still granted:

“Blinatumomab was granted accelerated approval for the treatment of adults and children with B-cell precursor (BCP) acute lymphoblastic leukemia.”

“In April 2020, the FDA approved selumetinib for pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas”


https://www.annalsofoncology.org/article/S0923-7534(22)00006-0/fulltext
Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News